Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01631292 · ClinicalTrials.gov registry record · NA

Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)

A NA study of Osteoporosis, sponsored by Rutgers University.

Completed
Registry status
NA
Development phase
81
Enrollment target
1
Study location

NCT01631292 is a NA study of Osteoporosis that has completed, run by Rutgers University. The registered enrollment target is 81 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01631292, a NA study of Osteoporosis, has completed, sponsored by Rutgers University.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
1
Study location

Study Summary

In this study, we will provide supplemental vitamin D in postmenopausal overweight/obese women, and hypothesize that it will not affect areal BMD, but will alter bone compartments (trabecular and cortical bone). In addition, higher vitamin D intake will increase serum 25OHD and suppress serum PTH and bone turnover during weight reduction. Secondary outcomes include the influence of vitamin D and weight loss on markers of insulin resistance and on cognitive tests of attention, learning, and memory.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT 600 IU Vitamin D3
  • DIETARY_SUPPLEMENT 2000 IU Vitamin D3
  • DIETARY_SUPPLEMENT 4000 IU Vitamin D3

Study Locations (1)

New Jersey

  • Rutgers University- Thompson Hall - New Brunswick

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2010-01
Est. Completion 2019-12-30
Phase NA

Sponsor

Rutgers University

18 total trials

What the Registry Record Tells You About NCT01631292

The ClinicalTrials.gov registry entry for NCT01631292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (95% lower). The listed sponsor is Rutgers University, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 3 interventions - of which 600 IU Vitamin D3 is the first listed.

NCT01631292 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT01631292 about?

NCT01631292 is a clinical study titled "Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)". In this study, we will provide supplemental vitamin D in postmenopausal overweight/obese women, and hypothesize that it will not affect areal BMD, but will alter bone compartments (trabecular and cortical bone). In addition, higher vitamin D intake will increase serum 25OHD and suppress serum PTH an...

What is the current status of trial NCT01631292?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2010-01. Estimated completion is 2019-12-30.

What conditions does trial NCT01631292 study?

This clinical trial studies the following conditions: Osteoporosis.

What interventions are being tested in trial NCT01631292?

The interventions under investigation include: 600 IU Vitamin D3 (DIETARY_SUPPLEMENT), 2000 IU Vitamin D3 (DIETARY_SUPPLEMENT), 4000 IU Vitamin D3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01631292?

This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01631292 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.